Article
Targeting the LKB1 tumor suppressor.
Current drug targets - 1 Jan 2014
Zhao Rui-Xun, Xu Zhi-Xiang
Abstract excerpt
LKB1 (also known as serine-threonine kinase 11, STK11) is a tumor suppressor, which is mutated or deleted in Peutz-Jeghers syndrome (PJS) and in a variety of cancers. Physiologically, LKB1 possesses multiple cellular functions in the regulation of cell bioenergetics metabolism, cell cycle arrest, embryo development, cell polarity, and apoptosis. New studies demonstrated that LKB1 may also play a role in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
